4 Key Priorities for Fighting Superbugs in 2021
Over the past year, COVID-19 has taken a grave toll in lives as well as on medical and health care systems worldwide. The pandemic has laid bare the importance of public health readiness and the myriad consequences when such a crisis strikes an unprepared population.
Even as the world is working to defeat COVID-19, another global health threat is lurking: antibiotic resistance. In the United States in recent years, there has been bipartisan momentum to prioritize the fight against superbugs that do not respond to available antibiotics, and now—more than ever—progress must not slow.
Policymakers and other stakeholders must learn from the pandemic and not hesitate in putting those insights to work.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.